Suppr超能文献

具有惰性临床病程的皮肤T细胞淋巴瘤非红皮病型白血病变体:缺乏T细胞受体/CD3表达的Th2型肿瘤细胞和共同浸润的杀肿瘤性CD8 T细胞。

Nonerythrodermic, leukemic variant of cutaneous T-cell lymphoma with indolent clinical course: Th2-type tumor cells lacking T-cell receptor/CD3 expression and coinfiltrating tumoricidal CD8 T cells.

作者信息

Tokura Y, Yagi H, Seo N, Takagi T, Takigawa M

机构信息

Department of Dermatology, Hamamatsu University School of Medicine, 3600 Handa-cho, Hamamatsu 431-3192, Japan.

出版信息

J Am Acad Dermatol. 2000 Nov;43(5 Pt 2):946-54. doi: 10.1067/mjd.2000.101880.

Abstract

As typically represented by Sézary syndrome, the leukemic form of cutaneous T-cell lymphoma (CTCL) mostly exhibits erythroderma. A patient with CTCL had slowly developing skin tumors as well as chronic leukemia. The tumor cell was CD4+ CD7- Th2 cells lacking T-cell receptor/CD3 complex and persistently occupied 27% to 48% of peripheral blood lymphocytes. In skin tumors, only 13% of tumor-infiltrating lymphocytes were malignant cells and substantial numbers of nonmalignant CD4+ or CD8+ T cells and B cells coinfiltrated. CD8+-infiltrating T cells had cytotoxic activity against the malignant T cell. Our case demonstrates the existence of the leukemic form of CTCL presenting with skin manifestation other than erythroderma and parapsoriatic patches. The nonerythrodermic feature and indolent course may be associated with the lack of T-cell receptor/CD3 expression and coinfiltration of a high percentage of nontumor lymphocytes, including tumoricidal CD8+ T cells.

摘要

以蕈样肉芽肿综合征为典型代表,皮肤T细胞淋巴瘤(CTCL)的白血病形式大多表现为红皮病。一名CTCL患者有缓慢发展的皮肤肿瘤以及慢性白血病。肿瘤细胞为缺乏T细胞受体/CD3复合物的CD4 + CD7 - Th2细胞,持续占据外周血淋巴细胞的27%至48%。在皮肤肿瘤中,仅13%的肿瘤浸润淋巴细胞为恶性细胞,大量非恶性的CD4 +或CD8 + T细胞以及B细胞共同浸润。浸润的CD8 + T细胞对恶性T细胞具有细胞毒性活性。我们的病例证明了存在除红皮病和副银屑病斑块之外还伴有皮肤表现的CTCL白血病形式。非红皮病特征和惰性病程可能与缺乏T细胞受体/CD3表达以及高比例非肿瘤淋巴细胞(包括具有杀肿瘤作用的CD8 + T细胞)的共同浸润有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验